Palvella Therapeutics, Inc. (PVLA) Non Operating Income (2016 - 2022)
Palvella Therapeutics (PVLA) has disclosed Non Operating Income for 11 consecutive years, with -$125000.0 as the latest value for Q4 2024.
- On a quarterly basis, Non Operating Income fell 129.48% to -$125000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$81000.0, a 111.38% decrease, with the full-year FY2024 number at $511000.0, down 28.23% from a year prior.
- Non Operating Income was -$125000.0 for Q4 2024 at Palvella Therapeutics, down from -$20000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $884000.0 in Q1 2021 to a low of -$1.8 million in Q4 2020.
- A 5-year average of $35894.7 and a median of $64000.0 in 2024 define the central range for Non Operating Income.
- Peak YoY movement for Non Operating Income: plummeted 2334.55% in 2020, then skyrocketed 1573.33% in 2021.
- Palvella Therapeutics' Non Operating Income stood at -$1.8 million in 2020, then surged by 120.62% to $378000.0 in 2021, then tumbled by 185.98% to -$325000.0 in 2022, then surged by 230.46% to $424000.0 in 2023, then plummeted by 129.48% to -$125000.0 in 2024.
- Per Business Quant, the three most recent readings for PVLA's Non Operating Income are -$125000.0 (Q4 2024), -$20000.0 (Q3 2024), and $64000.0 (Q2 2024).